Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1901 - 2000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1901 | 26733882 |
US |
43 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1902 | 26733884 |
US |
1 | |
Herpes zoster, Dermatitis atopic, |
||||
DUPILUMAB, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, UPADACITINIB, VALSARTAN, VALSARTAN ORAL, |
||||
| 1903 | 26733893 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1904 | 26733900 |
US |
50 | 1 |
Dermatitis atopic, Skin fissures, Skin haemorrhage, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1905 | 26733927 |
US |
4 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1906 | 26733954 |
US |
1 | |
Pain in extremity, Dermatitis atopic, |
||||
DUPILUMAB, LORATADINE PSEUDOEPHEDRINE SULFATE, LORATADINE AND PSEUDOEPHEDRINE SULFATE, |
||||
| 1907 | 26733961 |
US |
2 | |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1908 | 26733981 |
US |
64 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1909 | 26733987 |
US |
57 | 2 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1910 | 26733991 |
US |
23 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1911 | 26734009 |
US |
1 | |
Mood swings, Dermatitis atopic, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, |
||||
| 1912 | 26734035 |
US |
18 | 1 |
Infection, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1913 | 26734038 |
US |
30 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1914 | 26734046 |
US |
46 | 1 |
Dermatitis atopic, Skin fissures, Product dose omission issue, |
||||
DUPILUMAB, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, |
||||
| 1915 | 26734076 |
US |
53 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, GALCANEZUMAB-GNLM, TRALOKINUMAB-LDRM, |
||||
| 1916 | 26734102 |
US |
19 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1917 | 26734147 |
US |
9 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1918 | 26734159 |
US |
2 | |
Dermatitis atopic, Rash, Dry skin, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1919 | 26734167 |
US |
26 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, RUXOLITINIB, |
||||
| 1920 | 26734183 |
US |
26 | 2 |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1921 | 26734184 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1922 | 26734205 |
US |
9 | 1 |
Dermatitis atopic, Molluscum contagiosum, Accidental exposure to product, Exposure via skin contact, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1923 | 26734215 |
US |
32 | 2 |
Sleep disorder due to a general medical condition, Loss of personal independence in daily activities, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1924 | 26734223 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1925 | 26734225 |
US |
26 | 2 |
Eye pruritus, Dry eye, Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 1926 | 26734235 |
US |
2 | |
Injection site pain, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1927 | 26734249 |
US |
59 | 1 |
Dermatitis atopic, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1928 | 26734271 |
US |
46 | 1 |
Dermatitis atopic, Erythema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1929 | 26734296 |
US |
2 | |
Knee operation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1930 | 26734320 |
US |
29 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, IRON, |
||||
| 1931 | 26734345 |
US |
50 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1932 | 26734351 |
US |
64 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1933 | 26734357 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1934 | 26734378 |
US |
3 | 1 |
Dermatitis atopic, Skin disorder, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1935 | 26734389 |
US |
||
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1936 | 26734405 |
US |
16 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1937 | 26734407 |
US |
72 | 2 |
Dermatitis atopic, Pigmentation disorder, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1938 | 26734501 |
US |
4 | 2 |
Dermatitis contact, Rash, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1939 | 26734527 |
US |
38 | 2 |
Dizziness, Dermatitis atopic, Hyperhidrosis, |
||||
DUPILUMAB, DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, DESONIDE, FISH OIL, IRON, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVONORGESTREL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREGABALIN, SUMATRIPTAN SUCCINATE, TOPIRAMATE, VITAMIN C, ERGOCALCIFEROL, LISDEXAMFETAMINE DIMESYLATE, LEVOCETIRIZINE DIHYDROCHLORIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 1940 | 26734541 |
US |
65 | 1 |
Pruritus, Dermatitis atopic, Eczema, Dry skin, Skin fissures, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TIRZEPATIDE, VALSARTAN, VALSARTAN ORAL, |
||||
| 1941 | 26734550 |
US |
29 | 2 |
Dermatitis atopic, Therapeutic response shortened, Off label use, |
||||
DUPILUMAB, |
||||
| 1942 | 26734574 |
US |
63 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1943 | 26734584 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1944 | 26734585 |
US |
38 | 1 |
Dermatitis atopic, Rash macular, Pigmentation disorder, Dyshidrotic eczema, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1945 | 26734588 |
US |
34 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1946 | 26734593 |
US |
54 | 2 |
Pain, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1947 | 26734617 |
US |
3 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1948 | 26734622 |
US |
11 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1949 | 26734634 |
US |
47 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1950 | 26734704 |
US |
72 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1951 | 26734712 |
US |
2 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1952 | 26734739 |
US |
60 | 2 |
Sleep disorder due to a general medical condition, Dermatitis atopic, |
||||
DUPILUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1953 | 26734751 |
US |
44 | 2 |
Psoriasis, Dermatitis atopic, Hip arthroplasty, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1954 | 26734753 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1955 | 26734760 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1956 | 26734762 |
US |
46 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1957 | 26734773 |
US |
53 | 2 |
Dermatitis atopic, Product dose omission issue, Pruritus, Skin burning sensation, Rash, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CELECOXIB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHOCARBAMOL, METHOCARBAMOL TABLETS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, |
||||
| 1958 | 26734786 |
US |
11 | 2 |
Burning sensation, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1959 | 26734790 |
US |
69 | 1 |
Myocardial infarction, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CANDESARTAN CILEXETIL, TICAGRELOR, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EMPAGLIFLOZIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 1960 | 26734845 |
US |
74 | 2 |
Asthma, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1961 | 26734898 |
US |
1 | |
Dermatitis atopic, Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1962 | 26734914 |
US |
16 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1963 | 26734919 |
US |
23 | 2 |
Pruritus, Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1964 | 26734928 |
US |
55 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1965 | 26734937 |
US |
1 | |
Pain of skin, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1966 | 26734964 |
US |
2 | |
Respiratory syncytial virus infection, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1967 | 26735023 |
US |
76 | 2 |
Infection, Colectomy, Injection site pain, Injection site bruising, Injection site mass, Dermatitis atopic, Pruritus, Erythema, Rash, Inappropriate schedule of product administration, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1968 | 26735033 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1969 | 26735036 |
US |
1 | |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, DIPHENHYDRAMINE HYDROCHLORIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, IVERMECTIN, GUSELKUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1970 | 26735055 |
US |
13 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1971 | 26735076 |
US |
67 | 1 |
Pruritus, Skin exfoliation, Dermatitis atopic, Injection site pain, |
||||
DUPILUMAB, |
||||
| 1972 | 26735082 |
US |
3 | 1 |
Skin laceration, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, RUXOLITINIB, EPINEPHRINE, |
||||
| 1973 | 26735086 |
US |
20 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1974 | 26735096 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1975 | 26735101 |
US |
30 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1976 | 26735102 |
US |
51 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1977 | 26735125 |
US |
55 | 2 |
Dermatitis atopic, Rash pruritic, Rash macular, |
||||
DUPILUMAB, |
||||
| 1978 | 26735126 |
US |
33 | 2 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 1979 | 26735136 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1980 | 26735162 |
US |
24 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1981 | 26735186 |
US |
56 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1982 | 26735201 |
US |
79 | 2 |
Viral sinusitis, Cardiac disorder, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1983 | 26735212 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1984 | 26735227 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1985 | 26735232 |
US |
66 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1986 | 26735264 |
US |
20 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1987 | 26735276 |
US |
25 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1988 | 26735298 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1989 | 26735307 |
US |
73 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, ALLOPURINOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FINASTERIDE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, ZOLPIDEM TARTRATE, |
||||
| 1990 | 26735321 |
US |
56 | 1 |
Pruritus, Dry skin, Dermatitis atopic, |
||||
DUPILUMAB, LEBRIKIZUMAB-LBKZ, |
||||
| 1991 | 26735330 |
US |
51 | 2 |
Eczema, Rash, Surgery, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1992 | 26735346 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, AMITRIPTYLINE HYDROCHLORIDE, FENOFIBRATE, GLIPIZIDE, EMPAGLIFLOZIN, INSULIN GLARGINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIRZEPATIDE, PREGABALIN, PANTOPRAZOLE SODIUM, MODAFINIL, ROSUVASTATIN CALCIUM, |
||||
| 1993 | 26735350 |
US |
84 | 1 |
Dermatitis atopic, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 1994 | 26735351 |
US |
2 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1995 | 26735352 |
US |
44 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, APREMILAST, |
||||
| 1996 | 26735371 |
US |
61 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1997 | 26735379 |
US |
20 | 2 |
Dermatitis atopic, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1998 | 26735404 |
US |
7 | 2 |
Dermatitis atopic, Periorbital irritation, Skin irritation, |
||||
DUPILUMAB, |
||||
| 1999 | 26735405 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2000 | 26735407 |
US |
53 | 2 |
Dermatitis atopic, Skin fissures, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30